This measure identifies patients with new-onset atrial fibrillation during the measurement year who have had a thyroid function test 6 weeks before or after the diagnosis of atrial fibrillation.
This measure identifies adult patients newly diagnosed with rheumatoid arthritis during the first 8 months of the measurement year who received erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) lab tests either 4 months (3 months + 1-month grace period) before or after the initial diagnosis.
The percentage of patients aged 18 years and older with proteinuria who are taking an angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB)
Information From 2015 Submission
Optimal End Stage Renal Disease (ESRD) Starts is the percentage of new adult ESRD patients during the measurement period who experience a planned start of renal replacement therapy by receiving a preemptive kidney transplant, by initiating home dialysis (peritoneal dialysis or home hemodialysis), or by initiating outpatient in-center hemodialysis via arteriovenous fistula or arteriovenous graft.
Percentage of enrolled children under age 21 years who received a comprehensive or periodic oral evaluation within the reporting year.
The percentage of women aged 55 years and older, or men, aged 50 years and older, who are taking chronic steroids (>/=3 months), and are taking drugs to prevent osteoporosis
The percentage of women, aged 55 and older, or men, aged 50 and older, with a diagnosis of osteoporosis who are taking osteoporosis therapy.
The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.
The percentage of women 65-85 years of age who report ever having received a bone density test to check for osteoporosis.
This measure identifies patients 2 years of age and older with acute otitis externa who were or were not prescribed systemic antimicrobial therapy.